P589: IMPLICATIONS OF REGISTRY DATA FOR ACUTE MYELOID LEUKEMIA (AML) TREATMENT AND CARE DURING THE COVID-19 PANDEMIC

MLA

Bart Scott, et al. “P589: Implications of Registry Data for Acute Myeloid Leukemia (Aml) Treatment and Care during the Covid-19 Pandemic.” HemaSphere, vol. 7, Aug. 2023, p. e5950536. EBSCOhost, https://doi.org/10.1097/01.HS9.0000969260.59505.36.

APA

Bart Scott, Mikkael Sekeres, Guillermo Garcia-Manero, David Grinblatt, Irene Degutis, Pavel Kiselev, Ali Mcbride, Willem Heydendael, Edward Yu, & Gail Roboz. (2023). P589: Implications of Registry Data for Acute Myeloid Leukemia (Aml) Treatment and Care during the Covid-19 Pandemic. HemaSphere, 7, e5950536. https://doi.org/10.1097/01.HS9.0000969260.59505.36

Chicago

Bart Scott, Mikkael Sekeres, Guillermo Garcia-Manero, David Grinblatt, Irene Degutis, Pavel Kiselev, Ali Mcbride, Willem Heydendael, Edward Yu, and Gail Roboz. 2023. “P589: Implications of Registry Data for Acute Myeloid Leukemia (Aml) Treatment and Care during the Covid-19 Pandemic.” HemaSphere 7 (August): e5950536. doi:10.1097/01.HS9.0000969260.59505.36.